Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd > NOX Investor Relations

<< Previous

Bullboard Posts

Next >>

Comment by Ricky55on Oct 30, 2013 9:50am

145 Views

Post# 21861231

RE:NOX Investor Relations

Thanks for theses usefull info's.While i increase my position in NOX(i am now at 100 K) funds are selling.............Who is right in the story?Of course ,i am right because i see Nox as a long term investment(3 years for me approx.) and the funds:not so long and they also have to show good numbers at the end of the years,i guess.
Anyway,gold is there,project is well advance,good funding ,partners interest,is still there,so ,i will be patient till theses guys a done.There could be very good surprises with theses small company like this.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario